Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ACE | P12821 | 5/20 | 0.46 |
| ▸ | MME | P08473 | 5/20 | 0.44 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | ECE1 | P42892 | 2/20 | 0.41 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4966736 | 1.00 | PTGS1 (0.58) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL29379914 | 0.90 | PTGS1 (0.50) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL31391105 | 0.87 | PTGS1 (0.50) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL29351498 | 0.85 | ALDH1A1 (0.47) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL29637953 | 0.85 | PTGS1 (0.64) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL24130552 | 0.85 | ALDH1A1 (0.47) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL29410682 | 0.85 | ALDH1A1 (0.47) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL17283446 | 0.85 | ALDH1A1 (0.47) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL3495921 | 0.83 | ALDH1A1 (0.46) | PTGS1GSTK1ALDH1A1MAPTPTGS2 | |
| SCHEMBL6657992 | 0.83 | ALDH1A1 (0.46) | PTGS1GSTK1ALDH1A1MAPTPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655007-A1 | ANTIBODY OLIGONUCLEOTIDE CONJUGATES | Yale University (US) | 2025-12-03 | — | — | EP | claimed |
| CN-117050986-B | CpG oligonucleotide with immune stimulating activity and its use | 南京吉盛澳玛生物医药有限公司 | 2024-10-29 | — | — | CN | claimed |
| WO-2024158824-A1 | ANTIBODY OLIGONUCLEOTIDE CONJUGATES | YALE UNIVERSITY (US) | 2024-08-02 | — | — | WO | claimed |
| CN-117050986-A | CpG oligonucleotide with immune stimulating activity and its use | 南京吉盛澳玛生物医药有限公司 | 2023-11-14 | — | — | CN | claimed |
| US-20230242916-A1 | METHOD AND DRUG FOR TREATING HURLER SYNDROME | EDIGENE THERAPEUTICS (BEIJING) INC. (CN) | 2023-08-03 | — | — | US | claimed |
| US-20230242992-A1 | METHODS OF PREDICTING CANCER PROGRESSION | GMDX CO PTY LTD (AU) | 2023-08-03 | — | — | US | claimed |
| CN-116529835-A | Methods of predicting cancer progression | GMDX私人有限公司 | 2023-08-01 | — | — | CN | claimed |
| EP-4158070-A1 | METHODS OF PREDICTING CANCER PROGRESSION | GMDx Co Pty Ltd (AU) | 2023-04-05 | — | — | EP | claimed |
| WO-2021243401-A9 | METHODS OF PREDICTING CANCER PROGRESSION | GMDX CO PTY LTD (AU) | 2023-02-23 | — | — | WO | claimed |
| CN-115697420-A | Method and medicine for treating herler's syndrome | 北京辑因医疗科技有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-114807153-A | Multiple CpG oligodeoxynucleotide with immune stimulation activity and application thereof | 南京吉盛澳玛生物医药有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-113528582-B | Method and medicine for targeted editing of RNA based on LEAPER technology | 博雅辑因（北京）生物科技有限公司 | 2022-05-17 | — | — | CN | claimed |
| US-12637713-B2 | Methods and systems for phasing sequencing strands and long-range sequencing | ULTIMA GENOMICS, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260139309-A1 | METHODS AND SYSTEMS FOR EVALUATING MICROSATELLITE INSTABILITY STATUS | Life Technologies Corporation (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260132458-A1 | SYSTEMS AND METHODS FOR NUCLEIC ACID MISMATCH ERROR DETECTION | ULTIMA GENOMICS INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260112452-A1 | SYSTEMS AND METHODS FOR NUCLEIC ACID MISMATCH ERROR DETECTION APPLICATIONS | ULTIMA GENOMICS INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-1959919-A1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007068401-A1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2007-06-21 | — | — | WO | disclosed |
| US-6679761-B1 | CHEMICAL MECHANICAL POLISHING; ABRASIVE GRAINS, A PEPTIDE, AN OXIDIZER SUSPENDED IN AQUEOUS MEDIUM | SEIMI CHEMICAL CO., LTD. (JP) | 2004-01-20 | — | — | US | disclosed |
| EP-1235261-A1 | POLISHING COMPOUND FOR SEMICONDUCTOR CONTAINING PEPTIDE | Seimi Chemical Co., Ltd. (JP) | 2002-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637713-B2 | Methods and systems for phasing sequencing strands and long-range sequencing | POLQ, POLM, POLN | PTGS1 2975/4885GSTK1 3584/4885ALDH1A1 4013/4885 |
| US-20260112452-A1 | SYSTEMS AND METHODS FOR NUCLEIC ACID MISMATCH ERROR DETECTION APPLICATIONS | DNMT3A, TRMT1L, METTL16 | PTGS1 4555/4885GSTK1 4286/4885ALDH1A1 4109/4885 |
| US-20260139309-A1 | METHODS AND SYSTEMS FOR EVALUATING MICROSATELLITE INSTABILITY STATUS | MSH2, PMS2, MSH6 | PTGS1 4866/4885GSTK1 4120/4885ALDH1A1 4232/4885 |
| US-20260132458-A1 | SYSTEMS AND METHODS FOR NUCLEIC ACID MISMATCH ERROR DETECTION | UBE2V1, MCTS1, MICA | PTGS1 4715/4885GSTK1 4348/4885ALDH1A1 3844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.